InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ARROWHEAD PHARMACEUTICALS, INC.

ARWR Clue Score51
United States Fiscal year ends September CIK 0000879407 Results filed 4 Aug 2026
Add to watchlist

What the insiders did Net selling

By person

23 insiders · 427 transactions
337×

Christopher Anzalone holds 337 times base salary in stock. $331.11M of shares against $981.05K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher Anzalone last reported holding, valued at $87.30, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Christopher Richard Anzalone
Chief Executive Officer
—
$108.95M (106)
−$108.95M
3,792,739
$331.11M
+223.4%
Kenneth Allen Myszkowski
Chief Financial Officer
—
$23.21M (43)
−$23.21M
455,433
$39.76M
+19,305%
Patrick O'Brien
COO
—
$20.67M (50) scheduled
−$20.67M
547,408
$47.79M
+1,725%
James C Hamilton
Chief Medical Officer
—
$14.39M (56) scheduled
−$14.39M
226,958
$19.81M
+91.1%
Bruce D Given
Chief Operating Officer
—
$14.16M (34) scheduled
−$14.16M
850,730
$74.27M
+116.3%
Michael S Perry
Director
—
$9.33M (10)
−$9.33M
201,459
$17.59M
+22.1%
Douglas B Given
Director
$43.47K (1)
$5.18M (20)
−$5.13M
137,167
$11.97M
+148.1%
Martin Javier San
Chief Medical Officer
—
$4.15M (11)
−$4.15M
198,497
$17.33M
+32.3%
William D. Waddill
Director
—
$2.84M (16)
−$2.84M
56,563
$4.94M
+1,885,333%
Mauro Ferrari
Director
—
$2.34M (7)
−$2.34M
69,053
$6.03M
—
Curt Bradshaw
Chief Scientific Officer
—
$2.16M (2)
−$2.16M
0
$0.00
−100.0%
Adeoye Y Olukotun
Director
—
$1.88M (12)
−$1.88M
31,600
$2.76M
+531.6%
Peter Brian Leone
VP, Strategic Bus. Initiatives
—
$1.77M (1) scheduled
−$1.77M
130,000
$11.35M
—
James Hassard
Chief Commercial Officer
—
$1.50M (2)
−$1.50M
105,750
$9.23M
−15.4%
Victoria Vakiener
Director
—
$1.14M (8) scheduled
−$1.14M
35,723
$3.12M
+107.9%
Daniel Joseph Apel
Chief Financial Officer
—
$934.29K (3) scheduled
−$934.29K
162,905
$14.22M
+61.3%
Zhen Li
Snr. VP, Chem and Non-Clin Dev
—
$580.77K (1)
−$580.77K
201,700
$17.61M
+20.6%
Backer Marianne De
Director
$184.71K (10)
$740.43K (4)
−$555.72K
31,267
$2.73M
+525.3%
Tracie Oliver
Chief Commercial Officer
—
$555.13K (3)
−$555.13K
127,107
$11.10M
+81.6%
Hongbo Lu
Director
$82.99K (3)
$228.33K (1) scheduled
−$145.34K
52,012
$4.54M
+89.6%
Edward W Frykman
Director
—
—
—
148,852
$12.99M
+101.6%
Douglas S Ingram
Director
—
—
—
46,215
$4.03M
—
Matthew Gregory Cohen
Director
—
—
—
11,882
$1.04M
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.